Breathlessness in patients with intrathoracic malignancy Cancer Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Intractable breathlessness resulting from primary or secondary malignant lung disease in the palliative setting where the underlying cause has been maximally treated 2. All identified reversible causes of the breathlessness have been treated if appropriate to do so, in the opinion of the attending clinician 3. Karnofsky Performance Status (KPS) greater than 40% 4. Aged greater than 18 years, either sex 5. Willingness to attend for breathlessness training 6. Ability to give informed consent 7. Expected prognosis of at least 3 months in the opinion of the attending clinician
Exclusion criteria
Exclusion criteria: 1. Inability to give informed consent 2. Intercurrent illness or co-morbidities making completion of the physiotherapy breathlessness course (PBC) course unlikely 3. Rapidly worsening breathlessness requiring urgent medical intervention 4. Palliative radiotherapy to chest in previous 4 weeks 5. Radical radiotherapy in previous 6 months 6. Chemotherapy or change in anti-cancer hormone treatment in previous 2 weeks
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recruitment, retention and variability of breathlessness severity (Numerical Rating Scale [NRS] worst breathlessness over last 24 hours) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. NRS average breathlessness over last 24 hours 2. NRS breathlessness "now" 3. NRS distress due to breathlessness 4. NRS coping with breathlessness 5. NRS satisfaction of care 6. Brief COPE 7. Hospital Anxiety and Depression scale (HAD) 8. Euroqol EQ-5D (EQ-5D) 9. Visual Analogue Scale (VAS) | — |
Countries
United Kingdom